Epigenetics in bladder cancer (Q37243940)

19 August 2017

1 reference

title

Epigenetics in bladder cancer (English)

1 reference

19 August 2017

1 reference

Hideki Enokida

1

1 reference

19 August 2017

Masayuki Nakagawa

series ordinal

2

1 reference

19 August 2017

publication date

15 August 2008

1 reference

International Journal of Clinical Oncology

19 August 2017

published in

1 reference

19 August 2017

volume

13

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

298-307

1 reference

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0811-1

Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0811-1

Pi-class glutathione S-transferase: regulation and function.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0811-1

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Multiple mechanisms downregulate CDKN1C in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Epigenetic Inactivation of SFRP Genes and TP53 Alteration Act Jointly as Markers of Invasive Bladder Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Frequent hypermethylation of promoter region ofRASSF1A in tumor tissues and voided urine of urinary bladder cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

DNA methylation as a therapeutic target in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

High sensitivity mapping of methylated cytosines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Cancer. Developing molecular biomarkers for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Controlling the double helix

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Global cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Frequent hypermethylation of the RASSF1A gene in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Cell division is required for de novo methylation of CpG islands in bladder cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Examination of IGF2 and H19 loss of imprinting in bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Inhibitors of histone deacetylase are potentially effective anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Cell cycle regulators and their abnormalities in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Methylation and the genome: the power of a small amendment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Aberrant methylation of genes in low-grade astrocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Oncomirs - microRNAs with a role in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Using expression profiling data to identify human microRNA targets

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Epigenetics: regulation through repression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Promoter hypermethylation identifies progression risk in bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Acetylation and methylation in nuclear receptor gene activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Progressive increases in de novo methylation of CpG islands in bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

CpG islands in vertebrate genomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

High frequency of alterations in DNA methylation in adenocarcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Cancer statistics, 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Translating the Histone Code

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Identification of novel genes coding for small expressed RNAs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

CpG islands as genomic footprints of promoters that are associated with replication origins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Carcinogen exposure and gene promoter hypermethylation in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

CpG-rich islands and the function of DNA methylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18704629

12 December 2020

10.1007/S10147-008-0811-1

Identifiers

DOI

1 reference

19 August 2017

1 reference